Geftib Tablet is used for Treatment of metastatic non-small cell lung cancer in tumors with epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations and other conditions. Geftib Tablet may also be used for purposes not listed in this medication guide.
Geftib Tablet contains Gefitinib as an active ingredient. Geftib Tablet works by blocking signalling of epidermal growth factor receptor dependent proliferation.
Geftib Tablet – Side-effects
The following is a list of possible side-effects that may occur from all constituting ingredients of Geftib Tablet. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.

• Skin reactions
• Nail disorders
• Diarrhea
• Vomiting
• Nausea
• Stomatitis
• Decreased appetite
• Conjunctivitis
• Blepharitis
• Dry eye

Geftib Tablet – Precautions & How to Use
Before using Geftib Tablet, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below :

• Avoid concomitant use of this drug with proton pump inhibitors
• Contact doctor for new onset or worsening of pulmonary symptoms such as dyspnea, cough and fever
• Contact doctor for severe or persistent diarrhea
• Contact doctor if developping eye symptoms, lacrimation, light sensitivity, blurred vision, eye pain, red eye, or changes in vision
• Discontinue breast-feeding during treatment with this drug
• If treatment with a proton-pump inhibitor is required, take this drug 12 hours after the last dose or 12 hours before the next dose of the proton-pump inhibitor
• Monitor your liver function

Geftib Tablet is used for Treatment of metastatic non-small cell lung cancer in tumors with epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations and other conditions. Geftib Tablet may also be used for purposes not listed in this medication guide.
Geftib Tablet contains Gefitinib as an active ingredient. Geftib Tablet works by blocking signalling of epidermal growth factor receptor dependent proliferation.
Geftib Tablet – Side-effects
The following is a list of possible side-effects that may occur from all constituting ingredients of Geftib Tablet. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.

• Skin reactions
• Nail disorders
• Diarrhea
• Vomiting
• Nausea
• Stomatitis
• Decreased appetite
• Conjunctivitis
• Blepharitis
• Dry eye

Geftib Tablet – Precautions & How to Use
Before using Geftib Tablet, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below :

• Avoid concomitant use of this drug with proton pump inhibitors
• Contact doctor for new onset or worsening of pulmonary symptoms such as dyspnea, cough and fever
• Contact doctor for severe or persistent diarrhea
• Contact doctor if developping eye symptoms, lacrimation, light sensitivity, blurred vision, eye pain, red eye, or changes in vision
• Discontinue breast-feeding during treatment with this drug
• If treatment with a proton-pump inhibitor is required, take this drug 12 hours after the last dose or 12 hours before the next dose of the proton-pump inhibitor
• Monitor your liver function